These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3539709)

  • 21. Effect of branched chain amino acid-enriched amino acid solution on normalization of plasma amino acids in hepatic encephalopathy.
    Liaw KY; Chang CN; Wei TC; Lin JK
    Taiwan Yi Xue Hui Za Zhi; 1985 Mar; 84(3):331-8. PubMed ID: 3860605
    [No Abstract]   [Full Text] [Related]  

  • 22. The usefulness of branched chain amino acids in patients with acute or chronic hepatic encephalopathy.
    Alexander WF; Spindel E; Harty RF; Cerda JJ
    Am J Gastroenterol; 1989 Feb; 84(2):91-6. PubMed ID: 2644820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Branched-chain amino acids for hepatic encephalopathy?
    Gluud C
    Hepatology; 1991 Apr; 13(4):812-3. PubMed ID: 1826283
    [No Abstract]   [Full Text] [Related]  

  • 24. Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis.
    Iwasa M; Matsumura K; Watanabe Y; Yamamoto M; Kaito M; Ikoma J; Gabazza EC; Takeda K; Adachi Y
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):733-7. PubMed ID: 12811303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study].
    Egberts EH; Schomerus H; Hamster W; Jürgens P
    Z Ernahrungswiss; 1986 Mar; 25(1):9-28. PubMed ID: 3524038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branched-chain amino acids for the treatment of hepatic encephalopathy.
    Med Lett Drugs Ther; 1983 Jul; 25(640):72. PubMed ID: 6865852
    [No Abstract]   [Full Text] [Related]  

  • 27. Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?
    Vergara M; Castro-Gutiérrez V; Rada G
    Medwave; 2016 Dec; 16(Suppl5):e6795. PubMed ID: 28024140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Branched chain amino acids in the treatment of hepatic encephalopathy.
    Rossi-Fanelli F
    Adv Exp Med Biol; 1990; 272():227-33. PubMed ID: 2103689
    [No Abstract]   [Full Text] [Related]  

  • 29. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
    Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B
    Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review.
    Metcalfe EL; Avenell A; Fraser A
    Clin Nutr; 2014 Dec; 33(6):958-65. PubMed ID: 24656171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Branched-chain amino acids and their ketoanalogs: therapeutic uses in patients with chronic liver or kidney failure].
    Bode JC
    Internist (Berl); 1985 Jul; 26(7):388-98. PubMed ID: 3897107
    [No Abstract]   [Full Text] [Related]  

  • 32. Total parenteral nutrition with F080 in cirrhotics with subclinical encephalopathy.
    Millikan WJ; Henderson JM; Warren WD; Riepe SP; Kutner MH; Wright-Bacon L; Epstein C; Parks RB
    Ann Surg; 1983 Mar; 197(3):294-304. PubMed ID: 6402994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis.
    Tajiri K; Futsukaichi Y; Kobayashi S; Yasumura S; Takahara T; Minemura M; Sugiyama T
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):321-328. PubMed ID: 30381621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Solutions of selective and branched-chain amino acids in the treatment of hepatic encephalopathy in cancer patients].
    Nahum M; Pesce L; Gori A; Borzone E; Poloniato G
    Clin Ter; 1984 Feb; 108(4):313-8. PubMed ID: 6232068
    [No Abstract]   [Full Text] [Related]  

  • 35. Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties.
    Marrone G; Serra A; Miele L; Biolato M; Liguori A; Grieco A; Gasbarrini A
    World J Gastroenterol; 2023 May; 29(19):2905-2915. PubMed ID: 37274800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amino acids in hepatic encephalopathy--effects of branched chain amino acid infusion on serum aminogram.
    Watanabe A; Takesue A; Higashi T; Nagashima N
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):346-57. PubMed ID: 525213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral BCAA in the treatment of chronic hepatic encephalopathy.
    Marchesini G; Bianchi G; Zoli M
    J Hepatol; 1991 Mar; 12(2):267. PubMed ID: 1888373
    [No Abstract]   [Full Text] [Related]  

  • 38. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New support for branched-chain amino acid supplementation in advanced hepatic failure.
    Mascarenhas R; Mobarhan S
    Nutr Rev; 2004 Jan; 62(1):33-8. PubMed ID: 14995055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
    Kanematsu T; Koyanagi N; Matsumata T; Kitano S; Takenaka K; Sugimachi K
    Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.